CLINICAL_TRIALS
trial_result
· 2014-06-16
Clinical Trial Update: 4 Weeks Treatment With Empagliflozin (BI 10773) in Japanese Type 2 Diabetic Patients (T2DM) [Phase 2]
Summary
A Phase 2 study evaluating four weeks of empagliflozin in Japanese patients with Type 2 diabetes mellitus has completed and posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Boehringer Ingelheim | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED | Results posted: 2014-06-16